Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01242800 · ClinicalTrials.gov registry record · NA
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
A NA study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 390
- Enrollment target
NCT01242800 is a NA study that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 390 participants.
The verdict
NCT01242800, a NA study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 390 participants
- Enrollment target
Study Summary
RATIONALE: The primary tumor might be a source of re-seeding of distant sites and therefore elimination of this source of metastasizing cells by early local therapy may be of benefit. PURPOSE: This randomized phase III trial is studying early surgery to see how well it works compared to standard palliative therapy in treating patients with stage IV breast cancer.
Interventions
- PROCEDURE therapeutic conventional surgery
- RADIATION radiation therapy
- PROCEDURE palliative surgery
- RADIATION palliative radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2011-05-16 |
| Est. Completion | 2022-12-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01242800
The ClinicalTrials.gov registry entry for NCT01242800 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which therapeutic conventional surgery is the first listed.
NCT01242800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01242800 about?
NCT01242800 is a clinical study titled "Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer". RATIONALE: The primary tumor might be a source of re-seeding of distant sites and therefore elimination of this source of metastasizing cells by early local therapy may be of benefit. PURPOSE: This randomized phase III trial is studying early surgery to see how well it works compared to standard pa...
What is the current status of trial NCT01242800?
This trial is currently completed. It is a NA study. The enrollment target is 390 participants. The study started on 2011-05-16. Estimated completion is 2022-12-21.
What interventions are being tested in trial NCT01242800?
The interventions under investigation include: therapeutic conventional surgery (PROCEDURE), radiation therapy (RADIATION), palliative surgery (PROCEDURE), palliative radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT01242800?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.